Last: | $0.4732 |
---|---|
Change Percent: | -1.57% |
Open: | $0.4808 |
Close: | $0.4732 |
High: | $0.4854 |
Low: | $0.4507 |
Volume: | 9,030 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4732 | $0.4808 | $0.4732 | $0.4854 | $0.4507 | 9,030 | 10-26-2022 |
$0.47335 | $0.43 | $0.47335 | $0.4997 | $0.43 | 58,954 | 10-25-2022 |
$0.4448 | $0.4414 | $0.4448 | $0.4778 | $0.4366 | 38,404 | 10-24-2022 |
$0.4551 | $0.47 | $0.4551 | $0.4761 | $0.4393 | 21,113 | 10-21-2022 |
$0.472 | $0.45 | $0.472 | $0.485 | $0.45 | 14,073 | 10-20-2022 |
$0.4639 | $0.5041 | $0.4639 | $0.5041 | $0.4639 | 10,129 | 10-19-2022 |
$0.4801 | $0.49 | $0.4801 | $0.52 | $0.46 | 43,221 | 10-18-2022 |
$0.49 | $0.542124 | $0.49 | $0.542124 | $0.4602 | 9,172 | 10-17-2022 |
$0.472 | $0.4911 | $0.472 | $0.5199 | $0.472 | 26,764 | 10-14-2022 |
$0.52 | $0.47 | $0.52 | $0.5257 | $0.45 | 7,934 | 10-13-2022 |
$0.51 | $0.49 | $0.51 | $0.54 | $0.49 | 33,870 | 10-12-2022 |
$0.5183 | $0.5446 | $0.5183 | $0.5446 | $0.5001 | 27,111 | 10-11-2022 |
$0.5498 | $0.55 | $0.5498 | $0.55 | $0.4719 | 60,697 | 10-10-2022 |
$0.4806 | $0.485101 | $0.4806 | $0.5074 | $0.48 | 34,705 | 10-07-2022 |
$0.5074 | $0.54 | $0.5074 | $0.54 | $0.485 | 33,701 | 10-06-2022 |
$0.5201 | $0.5922 | $0.5201 | $0.5922 | $0.5 | 94,142 | 10-05-2022 |
$0.5502 | $0.44 | $0.5502 | $0.71 | $0.43 | 755,084 | 10-04-2022 |
$0.4219 | $0.444 | $0.4219 | $0.444 | $0.4103 | 95,345 | 10-03-2022 |
$0.42 | $0.42 | $0.42 | $0.44 | $0.42 | 17,655 | 09-30-2022 |
$0.408 | $0.4359 | $0.408 | $0.4359 | $0.3803 | 57,912 | 09-29-2022 |
News, Short Squeeze, Breakout and More Instantly...
GBS Inc. Company Name:
GBS Stock Symbol:
NASDAQ Market:
The transaction further solidifies GBS’ leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reach GBS’ global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (G...
- Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the ...
NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the four...